Company Monitoring Page for Roche

latest headlines for company on cafepharma

Roche's Vabysmo lands clinical counterpunch in ophthalmology brawl with Eylea
Fierce Pharma
Thu, 10/27/22 - 11:02 am
Tags:
Roche, Genentech, Vabysmo, bispecific antibodies, Eylea
AstraZeneca beats Roche twice in a day
EP Vantage
Wed, 10/26/22 - 10:20 am
Tags:
AstraZeneca, Roche, SERD, breast cancer, Ipatasertib, capivasertib, Camizestrant
Roche issues voluntary recall for Susvimo over manufacturing issue
Endpoints
Sun, 10/23/22 - 06:57 pm
Tags:
Roche, Medtech, ocular implants, Susvimo, wet age-related macular degeneration, product recalls
Roche, Hookipa Pharma agree $25 million deal for arenaviral immunotherapy
Pharmaphorum
Fri, 10/21/22 - 10:18 am
Tags:
Roche, Hookipa, KRAS mutation, arenaviral, HB-700
Roche CEO Cautious on Alzheimer’s Trial Despite Eisai’s Success
Bloomberg
Wed, 10/19/22 - 10:35 am
Tags:
Roche, Pharma CEOs, Severin Schwan, Alzheimer's disease, Eisai, gantenerumab, lecanemab
Roche Scraps Mid-Phase Programs in Hepatitis B, Geographic Atrophy
BioSpace
Tue, 10/18/22 - 10:01 pm
Tags:
Roche, hepatitis B, geographic atrophy
Roche Q3 results show steep fall-off in COVID product sales
Pharmaphorum
Tue, 10/18/22 - 10:50 am
Tags:
Roche, earnings, COVID-19
Few safe havens surface in another down quarter for biopharma
EP Vantage
Fri, 10/14/22 - 10:03 am
Tags:
biopharma stocks, COVID-19, Eli Lilly, Bristol Myers Squibb, Merck, Daiichi Sankyo, Vertex Pharmaceuticals, Takeda, Neurocrine, Sarepta Therapeutics, Orion, Pfizer, GSK, Roche, Moderna Therapeutics, BeiGene, BioNTech, Novavax, CureVac
The gloom deepens for biopharma stocks
EP Vantage
Mon, 10/10/22 - 06:54 pm
Tags:
biopharma stocks, AbbVie, Alnylam, AstraZeneca, Biogen, CRISPR Therapeutics, Daiichi Sankyo, Eisai, Eli Lilly, GSK, Intellia Therapeutics, Regeneron, Roche, Sanofi, Sarepta Therapeutics
Bayer, Hua Medicine snag first-in-class nod in China for Roche castoff diabetes drug
Fierce Pharma
Mon, 10/10/22 - 10:57 am
Tags:
Hua Medicine, Bayer, Roche, China, diabetes, dorzagliatin
Roche nets FDA approval for HER2-low breast cancer test paired with AstraZeneca-Daiichi's Enhertu
Fierce Biotech
Wed, 10/5/22 - 07:07 pm
Tags:
Roche, FDA, diagnostics, Medtech, HER2-low breast cancer, Enhertu, AstraZeneca, Daiichi Sankyo
ICER Deems Hemophilia Gene Therapies Worth the $2.5M Price Tag
BioSpace
Thu, 09/15/22 - 10:14 am
Tags:
hemophilia, gene therapy, ICER, Biomarin, Chugai, Roche, CSL Behring
AstraZeneca, Eli Lilly and Roche among pharmaceutical companies upgraded for high returns on R&D investments, analysts say
Morningstar
Wed, 09/14/22 - 09:31 am
Tags:
Roche, AstraZeneca, Eli Lilly, R&D, drug pricing
ESMO: Bristol Myers, Roche fail in post-surgery kidney cancer. But is it good news for Merck's Keytruda?
Fierce Pharma
Mon, 09/12/22 - 10:57 am
Tags:
ESMO, Roche, Bristol Myers Squibb, kidney cancer, Keytruda, Merck, Opdivo, Yervoy
ESMO 2022 – Keytruda secures a renal cancer monopoly
EP Vantage
Thu, 09/8/22 - 12:03 am
Tags:
Merck, Keytruda, renal cancer, Bristol Myers Squibb, Roche, ESMO
Roche pays $250 million to acquire Good Therapeutics and its preclinical cancer therapy
Stat
Wed, 09/7/22 - 10:45 am
Tags:
Roche, M&A, Good Therapeutics, cancer, oncology
PhoreMost in drug target discovery collaboration with Roche
Pharma Times
Wed, 09/7/22 - 10:21 am
Tags:
Roche, PhoreMost, drug development
Brace for an end-of-year boost to drug approvals
EP Vantage
Fri, 09/2/22 - 12:14 pm
Tags:
FDA, drug approvals, Alnylam Pharmaceuticals, Apellis Pharmaceuticals, Bristol Myers Squibb, Eli Lilly, Gilead Sciences, Mirati Therapeutics, Moderna Therapeutics, Provention Bio, Roche, TG Therapeutics, Travere Therapeutics
Interchangeability without switching studies: FDA explains why a new Lucentis biosimilar may be a game-changer
Endpoints
Thu, 08/25/22 - 07:48 pm
Tags:
FDA, interchangeability, biosimilars, Lucentis, Roche, Coherus Biosciences, Cimerli
China's Jemincare nabs $650M biobucks pact with Roche's Genentech for prostate cancer hopeful
Fierce Biotech
Thu, 08/18/22 - 12:36 pm
Tags:
Roche, Genentech, China, Jemincare, biobucks, prostate cancer

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.